No Data
No Data
Bausch + Lomb's ONE By ONE And Biotrue Eye Care Recycling Programs Collect Over 100M Units Of Used Materials
Barclays Names Most and Least Affected Healthcare Companies From Tariffs
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
RBC Capital Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Cuts Target Price to $17
Bausch + Lomb's Q1 Earnings Expected in Line With Forecasts, RBC Says
Express News | RBC Capital Maintains Outperform on Bausch & Lomb, Lowers Price Target to $17
Benjamin’s : New CEO